Clinical, care and pharmaco therapeutic profile of patients in COVID-19 Intensive Care Units

Abstract

Objective: Evaluate the clinical and care profile and fármaco therapy used by patients in COVID-19 intensive care units. Methods: This is a cross-sectional, descriptive study carried out in a public hospital thatis a regional reference for emergency care, located in the South West of Bahia. Data were collected from medical records of patients diagnosed with COVID-19 and admitted to the ICUs in 2020 and 2021. The drugs analyzed were classified according to the Anatomical Therapeutic Chemical classification of the World Health Organization. Data were tabulated in Microsoft Excel® and statistical analysis was performed in the Statistical Package for the Social Sciences®, version 21.0. Results: A total of 488 medical records were included, 53.3% of the patients were male, 60.5% were elderly, with a mean age of 63.17 (SD ± 16.95) and systemic arterial hypertension (67.0%). Regarding the care provided, 66.2% used invasive mechanical ventilation and the most prescribed medications were antibiotics (94.7%), such as azithromycin (71.5%), andcorticosteroids (90.6%). Conclusion: It is concluded that there was a hig her prevalence of elderly patients and those with comorbidities as populations atrisk for severe forms of COVID-19, in addition to the high frequency of use o fthe drug azithromycin.